Flibanserin 90mg + oxytocin 100IU + tyrosine 50mg in one rapid-dissolve tablet, available only if prescribed after provider review.
$475 for 30 doses
Acts on serotonin receptors in the brain (5-HT1A and 5-HT2A) involved in desire signaling. Flibanserin is the active ingredient in an FDA-approved oral therapy for certain premenopausal women with hypoactive sexual desire disorder. This compounded formula is not FDA-approved.
A peptide hormone the body produces naturally. It is involved in bonding and stress-response signaling and has been studied for its role in arousal pathways.
An amino acid the body uses to produce dopamine and norepinephrine, neurotransmitters involved in motivation and mood signaling.
Flibanserin is the active ingredient in an FDA-approved oral therapy for certain premenopausal women with hypoactive sexual desire disorder. This compounded formula is not FDA-approved.
Oxytocin is a peptide hormone involved in bonding and stress-response signaling, studied for its role in arousal pathways. Tyrosine is an amino acid the body uses to produce dopamine.
Designed to dissolve in the mouth without water and be taken as directed by your provider.
This formula is prescribed only when a licensed provider determines it is appropriate based on the patient's history, medications, and treatment goals.
A 5-minute online health questionnaire — no appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
Your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose adjustments and refills handled online.
Your assessment takes about 5 minutes. A licensed provider reviews your information and determines whether treatment is appropriate.
Start Assessment — provider will determine if appropriate →
PT-141 (bremelanotide) is a subcutaneous injection that acts on melanocortin pathways in the central nervous system, prescribed when a licensed provider determines it is appropriate.
Tadalafil 10mg + bremelanotide 10mg + pregnenolone 10mg — blood-flow support plus bremelanotide, the active ingredient in an FDA-approved injectable therapy for certain women. This compounded oral formula is not FDA-approved.